50 Followers SGX:T14 - Tianjin ZX USD (USD 0.825) TIANJIN ZHONG XIN PHARM GROUP
Sector: Health Technology, Industry: Pharmaceuticals: Other
Add to Watchlist
Add Alert 

Yahoo Finance (Live Price)

USD 0.825    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

19 Oct 2020


19 Oct 2020

52 Wk Range: 0.505 - 0.99

Day's Range: 0.825 - 0.83

Last Volume: 26,000

Current Yield: 5.13%

Projected Yield: 5.44%

19 Oct 2020

Metric T14 S.Median
Beta 0.84 0.25
VaR 21.3 48.01
Liquidity 145.28K 1.01M


19 Oct 2020

PE: 7.41

Market Cap: 635.1M

Price Over Book: 0.818

Return On Equity: 11.3%

Shares By Insiders: 76%


CEO: Yan Li

Founded Year: 1992

Headquarters: Tianjin

Employees: 4,720

Sector: Health Technology

Industry: Pharmaceuticals: Other



Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.